Medication info

Cody Duo Tablet 80/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Korea Sintax Pharmaceutical Co., Ltd.
Appearance
Bright orange oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Expired

MFDS item code 201907052 · Approved 2019.10.04

This product's status changed to Expired on 2024.10.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food and should be taken with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, the dose should not exceed 80 mg of valsartan per day.

Ingredients

Manufacturer
Korea Sintax Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy. That is, it helps to effectively lower blood pressure in combination with other antihypertensive drugs.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food and should be taken with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, the dose should not exceed 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Those with an allergy to this medication or sulfonamide drugs should not take it, and it is contraindicated in patients with severe liver or kidney disorders. This medication should be administered cautiously in patients with specific conditions such as electrolyte imbalance, decreased kidney function, liver dysfunction, the elderly, or heart disease, and strict observation by a physician is required in such cases. Dizziness or drowsiness may occur during treatment, so caution is needed when driving or operating machinery. This medication may affect potassium levels, so potassium supplements or medications containing potassium should not be taken without consulting a doctor. This medication may make the skin sensitive to sunlight, so precautions against ultraviolet rays should be taken during treatment, and if any skin abnormalities occur, a doctor should be consulted immediately. While taking this medication, blood pressure, kidney function, and electrolyte levels should be regularly checked for abnormalities. There may be interactions with other medications, so if you are taking other medications, you must inform your doctor or pharmacist. In case of overdose, symptoms such as hypotension, arrhythmia, and electrolyte abnormalities may occur, so seek medical attention immediately, and treatment should be administered according to the symptoms. The safety and efficacy of this medication in children has not been established; therefore, its use in children is not recommended. Store this medication in a place out of reach of children, and keep it in its original container away from moisture.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, indigestion, shortness of breath, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myalgia, nausea, congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylactic-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, increased AST, palpitations, indigestion, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vesicular dermatitis, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, elevated blood lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, reduced appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, acute respiratory distress syndrome, hypersensitivity reactions, pneumonia, pulmonary edema, acute renal failure, kidney impairment, erythema multiforme, fever, acute angle-closure glaucoma, nausea, drowsiness, hypovolemia, arrhythmia, muscle spasm

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Bright orange oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.